Brief: Getinge Maintains Forecast Of Organic Sales Growth Of 3-5% In 2026
17/07/2026 07:01
BRIEF-Getinge Maintains Forecast Of Organic Sales Growth Of 3-5% In 2026 July 17 (Reuters) - Getinge publ AB GETIb.ST:
Q2 ADJUSTED EPS SEK 3.59
Q2 FREE CASH FLOW SEK 1,001 MILLION
Q2 ADJUSTED GROSS PROFIT SEK 4,645 MILLION
Q2 ADJUSTED EBITA SEK 1,478 MILLION VERSUS. ESTIMATE SEK 1,373 MILLION
WE MAINTAIN OUR FORECAST OF ORGANIC SALES GROWTH OF 3-5% IN 2026
OUTLOOK 2026: NET SALES FOR 2026 ARE EXPECTED TO INCREASE BY 3–5% ORGANICALLY, ADJUSTED FOR THE PHASE-OUT OF SURGICAL PERFUSION 1)
Source text: ID:nWkr3fg71Y
Further company coverage: GETIb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Getinge publ AB
See all newsEurope Research Roundup: Akzo Nobel, Handelsbanken, RS Group
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix (updated)
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix
Sweden's Getinge Q3 organic sales rise 2.1%
Brief: Getinge Q3 Adjusted EBITA SEK 1,278 Million